Most Viewed Articles on GWDN Last Week: Oct 1, 2012

Oct 01, 2012 | staff reporter

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

1) TCGA Team Reports on Findings from Comprehensive Breast Cancer Analysis
2) Shareholder Lawsuits Seek to Stop BGI's Buy of Complete Genomics
3) Piper Jaffray Downgrades Sequenom Stock
4) ACLU Files for Second Supreme Court Review of Myriad's Gene Patents
5) Stanford Study Reveals Cystic Fibrosis-related Shifts in Lung Microbiome

Breaking News

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.

Most Viewed Articles on GWDN Last Week: Oct 1, 2012

Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates

Veracyte Q2 Revenues More Than Double on Test Volume Spike

Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent

Qiagen Q2 Revenues Grow 28 Percent

CareDx Q2 Revenues Up 77 Percent

Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds

Booster Push

With Help from Mr. Fluffington, PurrhD

Man Charged With Threatening to Harm Fauci, Collins

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance

Exact Sciences Q2 Revenues Rise 62 Percent

Association for Molecular Pathology Issues Guidelines to Promote Genetic Variant Data Sharing

FDA Clears Promega Microsatellite Instability Test System

NYU Langone Health Gets FDA Clearance for Solid Tumor Gene Sequencing Test